Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Not Before Time, England Announces Conditional Reimbursement Plans

This article was originally published in Scrip

Executive Summary

Better late than never: the consultation on what happens next after England's Cancer Drugs Fund finishes on March 31, 2016 is finally out. NHS England and NICE, England's HTA body, have together published proposals that include the conditional reimbursement of promising drugs that under the old system would likely have been thwarted by uncertainties in the evidence supporting them.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts